IL33 and head and neck cancer: These results, coupled with the wound closure assay, suggest that IL-33 could induce a change toward a mesenchymal phenotype in HT29 cells through the activation of EMT as was described in a head and neck cancer model (33); nevertheless, the analysis of additional EMT markers is needed to confirm the involvement of this process.